Will Compass file its FDA approval application for COMP360 by Dec 31, 2026?

Compass Pathways has been sending its application for FDA approval of COMP360, a psilocybin treatment for depression that hasn't responded to other treatments, in pieces, and says the last piece lands in late 2026. This market asks whether it finishes by December 31.